← Leaderboards
Brian T Fisher
Duke University
$7,185,446
Attributed
$13,574,237
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,501,815 · 6
By mechanism
R01$12,777,582 · 3
U54$2,724,233 · 3
Top collaborators
- William J Steinbach22 shared
Most similar at Duke University
Same institution · by research overlap
- William J Steinbach$15,812,111
- William E Kraus$34,726,553
- Thomas G. Mitchell$8,151,291
- Melissa D Johnson$1,406,165
- Carl F Pieper$12,837,294
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodProspectiveChildFoundationsInfectionMorbidity - Disease RateSiteFundingAntifungal TherapyBloodInternationalMortalityEarly DiagnosisMultidisciplinaryGuidelinesCommunicable DiseasesFutureDesignPatient-Focused OutcomesUnited States National Institutes Of HealthAdultResearch PersonnelMoldsBenefits And Risks
Grant awards (24)
Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (PFN-STRIDE)$1,927,578
U54 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,223,727
R01 · FY2025 · AI
Pediatric Fungal Network's (PFN) STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (STRIDE) Project 1$614,447
U54 · FY2025 · AI · contact PI
Pediatric Fungal Network's (PFN) STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (STRIDE) Administrative Component$182,208
U54 · FY2025 · AI · contact PI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$28,350
R01 · FY2025 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,383,097
R01 · FY2024 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,394,565
R01 · FY2023 · AI
Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial$1,468,578
R01 · FY2022 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$703,340
R01 · FY2022 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$472,708
R01 · FY2021 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$305,715
R01 · FY2021 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$787,070
R01 · FY2020 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$798,798
R01 · FY2019 · AI
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections$820,854
R01 · FY2018 · AI
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$631,470
R01 · FY2018 · HD
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$640,677
R01 · FY2017 · HD
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$642,589
R01 · FY2016 · HD
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$642,649
R01 · FY2015 · HD
Fungal biomarkers for diagnosis and response to therapy for pediatric candidemia$691,645
R01 · FY2014 · HD